Hepatocellular adenoma surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | |A01=MRI features of hepatic adenoma }} | ||
{{familytree | | | | | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| | | | | | | | | }} | {{familytree | | | | | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| | | | | | | | | }} | ||
{{familytree | | | | | | | B01 | | | | | | | | | | B02 | | | | | | | | }} | {{familytree | | | | | | | B01 | | | | | | | | | | B02 | | | | | | | |B01=Asymptomatic|B02=Symptomatic }} | ||
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | |,|-|-|^|-|-|.| | | | | | }} | {{familytree | | | |,|-|-|-|^|-|-|-|.| | | | |,|-|-|^|-|-|.| | | | | | }} | ||
{{familytree | | | C01 | | | | | | C02 | | | C03 | | | | C04 | | | | | }} | {{familytree | | | C01 | | | | | | C02 | | | C03 | | | | C04 | | | | |C01=Male & glycogen storage disease|C02=Female|C03=Hemodynamically stable|C04=Hemodynamically unstable }} | ||
{{familytree | | | |!| | | | | | | |!| | | | |!| | | | | |!| | | | | | }} | {{familytree | | | |!| | | | | | | |!| | | | |!| | | | | |!| | | | | | }} | ||
{{familytree | | | D01 | | | | | | D02 | | | D03 | | | | D04 | | | | | }} | {{familytree | | | D01 | | | | | | D02 | | | D03 | | | | D04 | | | | |D01=Resection irrespective of size & sybtype|D02=Stop offending drugs|D03=Radiofrequency ablation resection|D04=Embolization resection }} | ||
{{familytree | | | | | | | | |,|-|-|^|-|-|-|-|-|-|.| | | | | | | | | | }} | {{familytree | | | | | | | | |,|-|-|^|-|-|-|-|-|-|.| | | | | | | | | | }} | ||
{{familytree | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | | }} | {{familytree | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | |E01=<5cm|E02=>5cm }} | ||
{{familytree | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | |!| | | | | | | | | | | }} | {{familytree | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | |!| | | | | | | | | | | }} | ||
{{familytree | | |!| | | |!| | | |!| | | |!| | | |!| | | | | | | | | | | | | }} | {{familytree | | |!| | | |!| | | |!| | | |!| | | |!| | | | | | | | | | | | | }} | ||
{{familytree | | F01 | | F02 | | F03 | | F04 | | F05 | | | | | | | | | | | | | }} | {{familytree | | F01 | | F02 | | F03 | | F04 | | F05 | | | | | | | | | | | | |F01=Steatotic (HNF1 a) Hepatic adenoma|F02=Inflammatory hepatic adenoma|F03=Beta catenin hepatic adenoma|F04=Otehrs|F05=Consider resection }} | ||
{{familytree | | |!| | | |!| | | |!| | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | |!| | | |!| | | |!| | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | G01 | | G02 | | G03 | | G04 | | | | | | | | | | | | | | | | |G01=Followup, genetic counselling for MODY & hepatic adenomatosis|G02=Close followup, treatment of obesity & discontinue obesity|G03=Biopsy & resection if confirmed|G04=Biopsy & treat based on subtype }} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 01:35, 11 January 2019
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma surgery On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma surgery |
|
Risk calculators and risk factors for Hepatocellular adenoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Zahir Ali Shaikh, MD[3]
Overview
There is no specific medical therapy for the hepatocellular adenomas. The wait and watch policy is recommended for hepatocellular adenoams <5cm following cessation of offending drugs (OCPs) and no further growth detected. Annual followup is scheduled with MRI or ultrasound until menopause.
Hepatocellular adenoma surgery
- There is no specific medical therapy for the hepatocellular adenoma.[1][2]
- Historically, hepatocellular adenomas were treated with a wait and watch policy, with surgical intervention recommended for larger (>5cm) tumors.
- In asymptomatic female patients of hepatocellular adenomas , the first step is to stop the offending drug (OCPs) and check adenoma size on followup.
- The wait and watch policy is recommended when hepatocellular adenomas are <5cm or regress (to <5cm) following cessation of offending drug (OCPs) and no further growth detected.
- An yearly followup with MRI or ultrasound is scheduled for patients untill menopause.
| MRI features of hepatic adenoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asymptomatic | Symptomatic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Male & glycogen storage disease | Female | Hemodynamically stable | Hemodynamically unstable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Resection irrespective of size & sybtype | Stop offending drugs | Radiofrequency ablation resection | Embolization resection | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| <5cm | >5cm | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Steatotic (HNF1 a) Hepatic adenoma | Inflammatory hepatic adenoma | Beta catenin hepatic adenoma | Otehrs | Consider resection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Followup, genetic counselling for MODY & hepatic adenomatosis | Close followup, treatment of obesity & discontinue obesity | Biopsy & resection if confirmed | Biopsy & treat based on subtype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Toso C, Majno P, Andres A, Rubbia-Brandt L, Berney T, Buhler L, Morel P, Mentha G (2005). "Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors". World J Gastroenterol. 11 (36): 5691–5. PMID 16237767.Full text
- ↑ Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC (1996). "Selective management of hepatic adenomas". Am Surg. 62 (10): 825–9. PMID 8813164.